ArticleBreast care (Basel, Switzerland)2018

The Warwick Experience of the Oncotype DX® Breast Recurrence Score® Assay as a Predictor of Chemotherapy Administration.

Mashuk Alam Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.